The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
23hon MSN
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth ...
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
This was the stock's second consecutive day of losses.
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback